Ships from British Columbia, Canada|No Customs, No Border Delays|Lab Verified|≥98% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|No Customs, No Border Delays|Lab Verified|≥98% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|No Customs, No Border Delays|Lab Verified|≥98% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|No Customs, No Border Delays|Lab Verified|≥98% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|
category guide

Cardiovascular / Natriuretic Research Peptides Guide

In-depth research guide covering 3 peptides in the Cardiovascular / Natriuretic category. Includes evidence ratings, mechanisms, and clinical status for each compound.

Overview

This guide covers 3 research peptides in the Cardiovascular / Natriuretic category. Each compound is evaluated on its evidence base, mechanism, safety profile, and current clinical status.

Nesiritide — FDA Approved (Declining Use)

Evidence: A | Status: FDA-approved (Natrecor, August 2001) for acute decompensated heart failure. Use declined significantly after ASCEND-HF trial (2011) showed no mortality benefit.

Nesiritide is a recombinant form of human B-type natriuretic peptide (BNP), a 32-amino-acid peptide (MW ~3464 g/mol) with a 17-residue disulfide ring structure.

Use cases: Acute Heart Failure, Hemodynamic Support

Retatrutide 20mg
In Stock

Retatrutide 20mg

20mg

$99 USD
BPC-157 5mg
In Stock

BPC-157 5mg

5mg

$34 USD
Ipamorelin 10mg
In Stock

Ipamorelin 10mg

10mg

$49 USD

Atrial Natriuretic Peptide — Approved in Japan / Established Biomarker

Evidence: B | Status: Carperitide (recombinant hANP) approved in Japan (1995) for acute heart failure. Not approved in the US, EU, or other Western markets.

Atrial natriuretic peptide (ANP) is a 28-amino-acid hormone (MW ~3080 g/mol) secreted primarily by atrial cardiomyocytes in response to atrial stretch from volume overload. It is a key regulator of blood volume, sodium balance, and blood pressure.

Use cases: Acute Heart Failure (Japan), Cardiac Biomarker, Cardiovascular Research

B-type Natriuretic Peptide — Established Biomarker / Therapeutic Basis

Evidence: B | Status: Established diagnostic biomarker for heart failure. Recombinant form (nesiritide) is FDA-approved for acute decompensated heart failure.

B-type natriuretic peptide (BNP) is a 32-amino-acid cardiac hormone (MW ~3464 g/mol) secreted primarily by ventricular cardiomyocytes in response to myocardial wall stress from volume overload or pressure overload.

Use cases: Heart Failure Diagnosis, Cardiac Biomarker, Cardiovascular Research

Shop Research Peptides

Retatrutide 20mg
In Stock

Retatrutide 20mg

20mg

$99 USD
BPC-157 5mg
In Stock

BPC-157 5mg

5mg

$34 USD
Ipamorelin 10mg
In Stock

Ipamorelin 10mg

10mg

$49 USD
Semaglutide 10mg
In Stock

Semaglutide 10mg

10mg

$49 USD
TB-500 5mg
In Stock

TB-500 5mg

5mg

$29 USD
Retatrutide 10mg
In Stock

Retatrutide 10mg

10mg

$64 USD
GHK-Cu 50mg
In Stock

GHK-Cu 50mg

50mg

$24 USD
Sermorelin 5mg
In Stock

Sermorelin 5mg

5mg

$34 USD
Tesamorelin 10mg
In Stock

Tesamorelin 10mg

10mg

$64 USD

Quality Documentation

Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.

Product cards on this page link to current catalog entries and available quality documentation.

Follow Research Updates

Get new research pages, product updates, tool releases, and quality resources from Volta.

Subscribe

Frequently Asked Questions

Related Research

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.